Ignite Creation Date:
2025-12-24 @ 11:21 PM
Ignite Modification Date:
2026-05-17 @ 3:52 AM
Study NCT ID:
NCT05206656
Status:
COMPLETED
Last Update Posted:
2022-11-23
First Post:
2021-12-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer
Sponsor:
Organization: